Growth factors in preeclampsia: A vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?

被引:45
作者
Conti, E. [1 ]
Zezza, L. [1 ]
Ralli, E. [2 ]
Caserta, D. [2 ]
Musumeci, M. B. [1 ]
Moscarini, M. [2 ]
Autore, C. [1 ]
Volpe, M. [1 ,3 ]
机构
[1] Univ Roma La Sapienza, Cardiol Clin & Mol Med Dept, I-00189 Rome, Italy
[2] Univ Roma La Sapienza, Dept Obstet Gynecol & Urol Sci, I-00189 Rome, Italy
[3] IRCCS Neuromed, Pozzilli, IS, Italy
关键词
Angiogenesis; Growth factors and cytokines; Insulin-like growth factor-1; Preeclampsia/pregnancy; Vasodilation; PLASMA PROTEIN-A; GESTATIONAL DIABETES-MELLITUS; FACTOR-BINDING PROTEIN-1; HUMAN CHORIONIC-GONADOTROPIN; SOLUBLE ENDOGLIN RELEASE; IGF-I LEVELS; HYPERTENSIVE DISORDERS; INSULIN-RESISTANCE; BLOOD-PRESSURE; TYROSINE KINASE-1;
D O I
10.1016/j.cytogfr.2013.05.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preeclampsia is the major cause of maternofetal and neonatal morbi-mortality including intrauterine growth retardation, miscarriages and stillbirths. Inadequate vascular dilation and angiogenesis represent the crucial underlying defect of gravidic hypertension, denoting a failed response to the vasodilatory and pro-angiogenic challenge imposed by pregnancy, especially if multifetal. A similar pathogenesis appears involved in gestational diabetes. In this review we aimed to provide a hint on understanding the deeply involved angiogenic disorders which eventually culminate in utero-placental failure. The key players in these complex processes may be found in an intricate network of growth factors (GFs) and GF inhibitors, controlled by several vascular risk factors modulated by environment and genes, which eventually impact on early and late cardiovascular outcomes of mother and fetus. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:411 / 425
页数:15
相关论文
共 181 条
[1]  
Agatisa Patricia K, 2004, Am J Physiol Heart Circ Physiol, V286, pH1389
[2]   The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia [J].
Aggarwal, P. K. ;
Chandel, N. ;
Jain, V. ;
Jha, V. .
JOURNAL OF HUMAN HYPERTENSION, 2012, 26 (04) :236-241
[3]   IMPAIRED CARDIAC ADJUSTMENT TO PREGNANCY IN TYPE-I DIABETES [J].
AIRAKSINEN, KEJ ;
IKAHEIMO, MJ ;
SALMELA, PI ;
KIRKINEN, P ;
LINNALUOTO, MK ;
TAKKUNEN, JT .
DIABETES CARE, 1986, 9 (04) :376-383
[4]   The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease [J].
Al-Habboubi, Hebah H. ;
Mahdi, Najat ;
Abu-Hijleh, Tala M. ;
Abu-Hijleh, Farah M. ;
Sater, Mai S. ;
Almawi, Wassim Y. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (05) :403-409
[5]   Effects of chronic administration of a heme oxygenase substrate or inhibitor on progression of the estrous cycle, pregnancy and lactation of Sprague-Dawley rats [J].
Alexandreanua, IC ;
Lawson, DM .
LIFE SCIENCES, 2002, 72 (02) :153-162
[6]   Review: Biochemical markers to predict preeclampsia [J].
Anderson, U. D. ;
Olsson, M. G. ;
Kristensen, K. H. ;
Akerstrom, B. ;
Hansson, S. R. .
PLACENTA, 2012, 33 :S42-S47
[7]   The vascular endothelial growth factor family in adverse pregnancy outcomes [J].
Andraweera, P. H. ;
Dekker, G. A. ;
Roberts, C. T. .
HUMAN REPRODUCTION UPDATE, 2012, 18 (04) :436-457
[8]   Cardiovascular and Systemic Microvascular Effects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer [J].
Belcik, J. Todd ;
Qi, Yue ;
Kaufmann, Beat A. ;
Xie, Aris ;
Bullens, Sherry ;
Morgan, Terry K. ;
Bagby, Susan P. ;
Kolumam, Ganesh ;
Kowalski, Joe ;
Oyer, Jon A. ;
Bunting, Stuart ;
Lindner, Jonathan R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (07) :618-625
[9]   First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequent gestational diabetes [J].
Beneventi, Fausta ;
Simonetta, Margherita ;
Lovati, Elisabetta ;
Albonico, Giulia ;
Tinelli, Carmine ;
Locatelli, Elena ;
Spinillo, Arsenio .
PRENATAL DIAGNOSIS, 2011, 31 (06) :523-528
[10]   Pregnancy-related mortality in the United States, 1991-1997 [J].
Berg, CJ ;
Chang, J ;
Callaghan, WM ;
Whitehead, SJ .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (02) :289-296